Literature DB >> 33132075

Precision of the Hologic Horizon A dual energy X-ray absorptiometry in the assessment of body composition.

Y M Cheung1, G Roff2, M Grossmann3.   

Abstract

BACKGROUND: As the number of individuals with obesity increases, so too will the demand for a precise, cost-effective and safe method to better risk-stratify this heterogenous population. Visceral adipose tissue (VAT) area, a body composition measurement has been associated with the many facets of the metabolic syndrome. AIM: To determine the precision of dual energy X-ray absorptiometry (DXA) in providing body composition measurements, including VAT area, using the Hologic Horizon A scanner.
METHOD: Thirty participants (mean age 64 years, 47% male), underwent two sequential body composition scans. The coefficient of variation (CV) and least significant change (LSC) were calculated for android/gynoid ratio, appendicular lean/height2, lean/height2, total body fat and lean mass, total body mass, and subcutaneous adipose tissue (SAT) and VAT area. Participants were stratified according to age (<70 or ≥70 years), body mass index (BMI) (≤30 kg/m2 or >30 kg/m2) and sex (male or female). The CV was calculated for each parameter and then analysed for differences between groups.
RESULTS: The CV for all parameters was <3% with the exception of SAT (3.86%). The CV of VAT area was 2.63% with a LSC at 95% confidence of 7.28%. Apart from the CV differences between males and females for android/gynoid ratio (male: 3.56% vs. female: 1.74%, p = 0.01) and SAT area (5.04% vs. 2.46%, p = 0.01), there were no significant differences identified between the calculated CV for all other body composition parameters when participants were stratified by age, BMI and sex.
CONCLUSION: DXA scanning, using the Hologic Horizon A system, is capable of providing precise body composition measurements.
Copyright © 2020 Asia Oceania Association for the Study of Obesity. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Body composition; Dual-energy X-ray absorptiometry; Metabolic syndrome; Precision; Visceral fat

Year:  2020        PMID: 33132075     DOI: 10.1016/j.orcp.2020.10.005

Source DB:  PubMed          Journal:  Obes Res Clin Pract        ISSN: 1871-403X            Impact factor:   2.288


  6 in total

Review 1.  Osteosarcopenia-The Role of Dual-Energy X-ray Absorptiometry (DXA) in Diagnostics.

Authors:  Aleksandra Gonera-Furman; Marek Bolanowski; Diana Jędrzejuk
Journal:  J Clin Med       Date:  2022-04-30       Impact factor: 4.964

2.  Nutritional Status Association With Sarcopenia in Patients Undergoing Maintenance Hemodialysis Assessed by Nutritional Risk Index.

Authors:  Masafumi Kurajoh; Katsuhito Mori; Mizuki Miyabe; Shota Matsufuji; Mitsuru Ichii; Tomoaki Morioka; Akane Kizu; Yoshihiro Tsujimoto; Masanori Emoto
Journal:  Front Nutr       Date:  2022-05-13

3.  Bone and body composition analyses by DXA in adults with GH deficiency: effects of long-term replacement therapy.

Authors:  Alessandro Rossini; Roberto Lanzi; Carlotta Galeone; Claudio Pelucchi; Mario Pennacchioni; Francesca Perticone; Marcella Sirtori; Marco Losa; Alessandro Rubinacci
Journal:  Endocrine       Date:  2021-07-30       Impact factor: 3.633

4.  Visceral Adipose Tissue Indices Independently Correlated with Obstructive Sleep Apnea in Patients with Type 2 Diabetes.

Authors:  Caiyu Zheng; Xuanling Zheng; Xiaoyan Lin; Jiawen Ye; Ziqing Xu; Huixian Hu; Wengui Wang; Caoxin Huang; Jianqing Tian; Changqin Liu
Journal:  J Diabetes Res       Date:  2022-02-10       Impact factor: 4.011

5.  Xanthine Oxidoreductase Inhibitor Use Associated With Reduced Risk of Sarcopenia and Severe Sarcopenia in Patients Undergoing Hemodialysis.

Authors:  Masafumi Kurajoh; Katsuhito Mori; Mizuki Miyabe; Shota Matsufuji; Akane Kizu; Yoshihiro Tsujimoto; Masanori Emoto
Journal:  Front Med (Lausanne)       Date:  2022-02-07

6.  Comparison between DXA and MRI for the Visceral Fat Assessment in Athletes.

Authors:  Hiroko Murata; Tomoyoshi Yagi; Taishi Midorikawa; Suguru Torii; Eri Takai; Motoko Taguchi
Journal:  Int J Sports Med       Date:  2022-02-02       Impact factor: 2.997

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.